National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey

Dursun, ABavbek, SMisirligil, ZErdener, FBuyukozturk, SAydin, OGemicioglu, BBayrak, PErkekol, FOYildirim, ZCilli, ABoz, ABAlpaydyn, AOKarakoc, GGorguner, MKarakaya, GIsik, RSapan, NBakirtas, A2024-07-182024-07-180105-45381398-9995http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10751EnglishNational safety data of post-marketing use of omalizumab in severe persistent asthma in TurkeyMeeting Abstract